in Aerospace

Dnata awarded UK MHRA certification for Good Distribution Practice

Posted 19 April 2018 · Add Comment

Global air services provider and UK ground handler, dnata, has been awarded certification for Good Distribution Practice (GDP) by the UK Medicines and Healthcare Products Regulatory Agency (UK MHRA).


Courtesy dnata

The UK MHRA granted dnata full Wholesaler Dealer Authorisation (WDA) after dnata completed the organisation’s Good Distribution Programme, while simultaneously investing into cutting-edge pharma handling technology at several of its facilities.

Dnata’s investment includes a sophisticated 24-hour warehouse monitoring system that has the ability to conduct temperature mapping and advise dnata operators ahead of any deviation in temperature. This, in, turn enables pre-planning, quick response to adapt to adverse weather conditions and assessment of potential transport routes for pharma products.

Temperature mapping is also routinely conducted within dnata’s facilities in the summer and winter to gauge average temperatures.

This leading-edge technology recently paid dividends when the cold front struck in early March and temperatures across the UK plummeted. dnata was able to prepare for the severe temperature onslaught, and ensure that all pharmaceuticals handled followed the optimum route, at temperatures that limited the risk of spoilage.

In addition, the company has installed automated handling systems that can store pharmaceuticals at variable temperature ranges.

In order to achieve certification, dnata was required to either review or make enhancements to its quality systems, operations documentation and facilities management practices – a 12 to 24-month process that it completed in just six months.

“We have invested in pharma-handling facilities across the UK in response to customer demand and in recognition of the growing importance of pharma cold-chain logistics,” said dnata UK CEO Gary Morgan.

“With world-class technology already in place at our facilities, the next logical step was to ensure standards compliance and achieve UK MHRA certification.  These initiatives not only demonstrate our ongoing focus on safety and quality, but also reinforce our commitment to our airline customers who operate in the fast-growing pharmaceutical transportation sector.”

* required field

Post a comment

Other Stories
Advertisement
Latest News

Culdrose Merlins join HMS Queen Elizabeth to support F-35 deck landings

Aircraft, aircrew and support personnel from 820 Naval Air Squadron (NAS) have embarked HMS Queen Elizabeth to support her forthcoming F-35B flight trials.

First ACJ320neo is assembled

The first ACJ320neo has been assembled on programme, fitted with CFM International LEAP-1A engines and painted in ACJ house-colours, in preparation for a first flight in the coming weeks.

CAA calls for more prosecutions of disruptive passengers

The UK Civil Aviation Authority today revealed that it had already received more than 200 incident reports about disruptive passengers from UK airlines in 2018 - before the busy summer flying season had even begun.

CGI to upgrade FC BISA for NATO interoperability

CGI has been awarded a £17 million four year contract by the UK Ministry of Defence (MoD) to provide a mid-life upgrade to the Fire Control Battlefield Information System Application (FC BISA).

Intertronics launches portable IUV101 LED UV curing spot lamp

To improve UV curing options available for a range of industries including aerospace and defence, adhesives specialist Intertronics has launched the IUV101 LED UV curing spot lamp.

CTS completes VIPER demo at US Military’s Cyber Quest

Chemring Technology Solutions (CTS) has completed the successful demonstration of VIPER, the world’s first Electronic Warfare (EW) manpack geo-fencing capability, at this year’s Cyber Quest.

ODU SK191217191218
See us at
SMIFAVSBT151118Aviation Africa 2019DVD18BT3105200918SMI GMSCBT3005081118AdvancedEngin BT1406011118